/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CCChemours Co |
|---|---|
| Last close | $13.28close 2026-11-09 |
| Change % | +4.16%close 2026-11-09 |
| Market cap | $2.0Bclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $5.8B⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofTTM ending 2026-09-30 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 0.1%TTM to 2026-09-30 |
| Net income | $-154000000⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofTTM ending 2026-09-30 Filing10-Q · 0001627223-26-000035 · filed 2026-11-05 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. Open the filing on EDGAR →Open the XBRL payload →CiteChemours Co (CC), us-gaap:NetIncomeLoss: -154,000,000 USD, trailing twelve months ended 2026-09-30, the sum of four filed quarters. Newest quarter from Form 10-Q, accession 0001627223-26-000035, filed 2026-11-05. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001627223/us-gaap/NetIncomeLoss.json |
| Net margin | -2.6%TTM to 2026-09-30 |
| EPS (diluted) | $-1.02⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofTTM ending 2026-09-30 Filing10-Q · 0001627223-26-000035 · filed 2026-11-05 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. Open the filing on EDGAR →Open the XBRL payload →CiteChemours Co (CC), us-gaap:EarningsPerShareDiluted: -1.02 USD per share, trailing twelve months ended 2026-09-30, the sum of four filed quarters. Newest quarter from Form 10-Q, accession 0001627223-26-000035, filed 2026-11-05. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001627223/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 5FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | inputs not filed |
| Beneish M-ScoreUNVALIDATED | -2.90FY to 2025-12-31 |
| Next earnings | 02-13 → 02-23 |